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Abstract
Objective—To study risk factors for revision of primary total hip replacement (THR) in a US
population-based sample.
Methods—Using Medicare claims, we identified beneficiaries from 29 US states who underwent
primary THR between 7/1/1995 and 6/30/1996, and followed them through 12/31/2008. Potential
cases had ICD-9 codes indicating revision THR. Each case was matched by state with one control
THR recipient who was alive and unrevised when the case had revision THR. We abstracted
hospital records to document potential risk factors. We examined associations between
preoperative factors and revision risk using multivariate conditional logistic regression.
Results—The analysis data set consisted of 719/836 case-control pairs with complete data for
analysis variables. Factors associated with higher revision odds in multivariate models were age
≤75 at primary surgery (OR 1.52, 95% CI 1.20, 1.92), height in highest tertile (OR 1.40, 95% CI
1.06, 1.85), weight in highest tertile (OR 1.66, 95% CI 1.24, 2.22), cemented femoral component
(OR 1.44, 95% CI 1.10, 1.87), prior contralateral primary THR (OR 1.36, 95% CI 1.05, 1.76),
other prior orthopedic surgery (OR 1.45, 95% CI 1.13, 1.84), and living with others (versus alone;
OR 1.26, 95% CI 0.99, 1.61).
Conclusion—This first US population-based case-control study of risk factors for revision of
primary THR showed that younger, taller, and heavier patients and those receiving a cemented
femoral component had greater likelihood of revision THR over twelve-year follow-up. Effects of
age and body size on revision risk should be addressed by clinicians with patients considering
primary THR.
Total hip replacement (THR) is a highly effective intervention to improve pain and function
in the hip affected by advanced arthritis. More than 280,000 primary THRs are performed
every year in the US.1 However, some patients experience symptomatic prosthesis failure
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due to a range of problems, including loosening, infection, or dislocation. A subset of these
patients subsequently undergoes revision surgery. Prior estimates place the revision risk at
about 1% per year.2, 3 Due in part to the growing number of primary procedures, revision
THR is now performed on over 50,000 people every year in the United States at a direct cost
exceeding $1 billion.1
Prior studies identify male sex,4, 5 younger age,4–7 high comorbidity score,4, 6, 8, 9 and
uncemented prostheses5 as risk factors for revision of primary THR. Low surgeon THR
procedure volume has also been cited as a risk factor, but only in the early period after
revision.8, 10 Additional risk factors have been associated with specific indications for
revision, such as infection.11–15 Study of revision risk in primary THR is challenging
because it is a relatively infrequent outcome that can occur a decade or more after the
primary procedure. An additional methodological challenge is the high mortality rate among
older patients, who often face a higher risk of death than of revision.2, 16
The objective of this study was to evaluate the risk factors for revision of primary THR in
the US Medicare population over twelve years of follow-up. We hypothesized that younger
age, male sex, and greater biomechanical load (as represented by height and weight) would
be associated with revision risk.
PATIENTS AND METHODS
Study Design
We performed a nested case-control study of risk factors for revision of hip replacement.
Selection of Patients
A sample of 46,877 Medicare beneficiaries in 29 US states who were reported to have
undergone primary THR surgery between 7/1/1995 and 6/30/1996 were followed in annual
Medicare Provider Analysis and Review (MedPAR) billing records through the end of 2008
to identify hospital admissions for revision THR surgery. The states were chosen to provide
a wide geographic range across the US. The surgery procedure code identifying revision
surgery was 8153 until September, 2005, when new ICD-9-CM procedure codes of 0070
through 0073 were added for revision THR. We selected all patients with a code for revision
hip replacement surgery, which yielded 3,647 putative cases. For each of these potential
cases, we randomly selected one control from patients who had primary THR in the same
state and were alive and not revised as of the case revision surgery date. All patients were
censored at the date of a second total hip replacement (in order to reduce the confusion
caused by revisions performed on the contralateral rather than the index hip). Cases were
eligible to be controls until two years prior to their revision surgery, since this was
considered a conservative estimate for the first appearance of symptoms ultimately leading
to revision.
Identification of Cases and Controls
For each of the 3,647 potential cases and 3,647 controls, patient medical records for the
dates of the primary THR surgery were requested from the hospitals. For each of the cases,
patient medical records for the date of the revision surgery were also requested. Ineligible
cases were those whose primary or revision record was inaccessible, whose index surgery
was not a primary THR, whose putative revision surgery was shown on the medical record
not to be a revision THR, whose primary and revision surgeries were on opposite sides, or
whose record showed an ineligible indication for THR (e.g., tumor, acute fracture of hip/
pelvis or history of hip infection). Ineligible controls were those whose index surgery was
not a primary THR or whose record indicated an ineligible indication for THR. Cases
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matched to controls whose records were ineligible or unobtainable were then matched to
other eligible controls from providers in the same state. Figures 1 and 2 show the steps used
to select matched cases and controls.
Medical Record Review
The medical charts were abstracted by trained medical abstractors at Information Collection
Enterprises in York, PA. Data collected included demographic information, surgical data to
determine case eligibility, patient history, lifestyle factors, and operative variables.
Data Elements
Demographic data included age at surgery (dichotomized as 65–75 and >75 years), sex, race
(categorized as white or non-white), Medicaid buy-in (a variable that identifies subjects with
very low income), and zip code at time of surgery (for classification of rural, suburban or
urban residence).
Patient history variables, reflecting patient status prior to the primary THR, included prior
surgery on index and non-index hip, other major musculoskeletal surgeries, underlying
disease leading to THR, height, weight, and comorbidities. The Charlson Comorbidity
Score17, 18 was calculated from comorbidities documented in the medical chart at the time of
primary THR and was dichotomized as 0–1 or >1 for the analysis. Body mass index (BMI)
was calculated from height and weight (kilogram/meter2) at time of THR primary surgery
and divided into tertiles (<25 / 25–30 / ≥ 30). Height and weight were divided into by tertiles
by sex (males: height in inches ≤68 / 69–71 / ≥72 and weight in pounds ≤177 / 178–203 /
≥204; females: height in inches ≤63 / 64–65 / ≥66 and weight in pounds ≤145 / 146–173 /
≥174).
Lifestyle factors ascertained at time of primary THR surgery included smoking habits, both
current and past, alcohol use, and living situation (living alone vs. living with others).
Operative variables pertaining to the primary THR included type of anesthesia (general/
spinal/epidural), American Society of Anesthesiologists Physical Status Scores (ASA
Score), duration of the primary THR surgery (<2.5 hrs vs. ≥2.5 hrs), and acetabular and
femoral prosthesis fixations (cemented or cementless).
STATISTICAL METHODS
Comparison of available and unavailable records—We compared characteristics
(ascertained from Medicare claims data) of subjects whose records were obtained from
hospitals with subjects whose records were not obtained using the chi-square test for
categorical variables and the t-test for continuous factors.
Main analysis with matched data—The goal of the analysis was to identify factors
associated with revision of a THR. The analysis cohort consisted of those with complete
data for the factors being analyzed. Bivariate associations between potential risk factors and
revision status were evaluated with McNemar’s chi-square test and conditional logistic
regression. Variables associated with revision status with p≤0.05 were advanced to
multivariate conditional logistic regression models.
Sensitivity analysis—The predictor variables with the most missing data were height and
weight. Subjects with missing data on one or both of these variables were no more likely to
have had a revision (i.e., to be a case) than subjects with complete data on these variables
(chi-square p=0.61). Weight and height were moderately correlated (r = 0.39 in males and
0.24 in females). These observations support the imputation we performed with the SAS MI
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and MIANALYZE procedures, which assume that data are missing at random and that the
probability of missing values for a given variable is conditioned on the other variables in the
analysis.
Unmatched analyses were also performed predicting case status using logistic regression,
adjusting for covariates in the final model plus state of hospital for the primary THR
surgery. For one of these analyses, a four-category variable was created representing
combinations of cemented and uncemented acetabular and femoral components.
All analyses were done using SAS version 9.1 for UNIX (SAS Institute, Cary, NC (2003)).
RESULTS
Description of Study Sample
Record accrual—From the 3,647 potential cases for whom medical records were
requested, 836 (23%) eligible cases (pairs of primary and revision records) were obtained.
Of the unavailable potential cases, hospitals did not respond to 56% of our requests and
hospitals were not able to obtain the medical record in 36%. Another 7% of subjects were
ineligible because revision surgery was performed on the non-index hip. Reasons reported
by hospitals for not obtaining and/or sending the records for abstraction included destruction
of records (47%), need for patient consent (14%), inability to find record (13%), hospital
refusal (10%), as well as hospital closure (7%), cost (5%), and IRB issues (4%).
An analysis comparing eligible cases and controls whose records were obtained to potential
cases and controls whose records were not obtained suggested that our study sample was
similar to the patients whose records were unavailable with respect to age, sex, race, and
comorbidity (Appendix Table 1). However, subjects who were included in the analysis were
less likely to be operated upon at a high-volume hospital (> 100 THR/year in Medicare
population) than subjects whose records were not obtained. This pattern was observed for
both cases and controls.
Characteristics of analysis cohort—The sample for the main analysis included the
719 case-control pairs with complete data for the predictors of interest. The average age of
these 1,438 patients was 74.0 years (SD±5.8), 39% were male, 34% had BMI ≥ 30, 54% had
at least two Charlson comorbidities, 5% had Medicaid coverage, and 5% were non-white.
Characteristics of cases at time of revision THR—Case medical records showed
multiple clinical indications for revision of the total hip replacement. The reasons cited, in
order of frequency, were: loosening of the prosthesis (51%), repeated dislocations (38%),
polyethylene liner wear (14%), osteolysis (11%), periprosthetic fracture of the femur or
pelvis (9%) and infection of the THR (5%). When each failure mechanism was stratified by
time to revision (≤ 2 years vs. > 2 years), dislocations were associated with earlier revisions
(p<0.0001), while loosening, osteolysis, liner wear and periprosthetic fracture were
associated with later revisions (p<0.0001, p<0.0001, p<0.0001 and p=0.04, respectively).
The data did not suggest that the risk of revision for infection varied over time.
Results of Bivariate Analysis
Cases were significantly younger than controls, with 67% of the cases vs. 55% of the
controls between 65 and 75 years old, yielding an OR for comparison with those over 75 of
1.7 (95% CI 1.4, 2.1). Cases were significantly more likely than controls to live with others
as opposed to alone at the time of primary THR (OR 1.4, 95% CI 1.1, 1.7). Cases were also
more likely than controls to have had prior contralateral total hip replacement (OR 1.4, 95%
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CI 1.1, 1.8), to have had prior major musculoskeletal surgery (OR 1.5, 95% CI 1.2, 1.9), to
have had a cemented (as opposed to uncemented) femoral component implanted at the index
THR (OR 1.3, 95% CI 1.0, 1.7), to be obese (BMI ≥30) (OR 1.8, 95% CI 1.4, 2.4), and to be
in the highest tertile for height (1.6, 95% CI 1.3, 2.1) and weight (2.0, 95% CI 1.6, 2.7)
(Table 1). We did not observe clinically or statistically meaningful differences between
cases and controls in a range of preoperative and operative features including sex, race,
Charlson comorbidity count, Medicaid eligibility, residence population density, smoking
status, alcohol intake, hospital and surgeon annual primary THR volume, ASA class at
primary surgery, type of anesthesia, fixation of acetabular component, 6/8 prosthesis
manufacturers, and surgery duration (for full results of the bivariate analysis, see Appendix
Table 2).
Results of Multivariate Analysis
We built multivariate conditional logistic regression models predicting revision using
variables statistically significantly associated with case status in unadjusted models. With
the exception of the prosthesis manufacturer variables, all variables -- including age ≤75
(OR 1.5, 95% CI 1.2, 1.9), living with others (OR 1.3, 95% CI 1.0, 1.6), prior contralateral
THR (OR 1.4, 95% CI 1.1, 1.8), prior musculoskeletal surgery (OR 1.4, 95% CI 1.1, 1.8),
cemented femoral component (OR 1.4, 95% CI 1.1, 1.9), height in the highest tertile (OR
1.4, 95% CI 1.1, 1.9) and weight in the highest tertile (OR 1.7, 95% CI 1.2, 2.2) -- remained
independent significant predictors of revision (Table 1).
Results of Sensitivity Analyses
Alternative models replacing weight in tertiles with BMI in tertiles yielded qualitatively the
same results as the main model, with height in the highest tertile as well as BMI in the
highest tertile being significantly associated with revision risk (OR 1.7, 95% CI 1.3, 2.2 for
height; OR 1.7, 95% CI 1.3, 2.3 for BMI). However, in models replacing height in tertiles
with BMI in tertiles, BMI was no longer statistically significantly associated with revision
risk. The main analysis was also repeated after excluding the 35 case-control pairs in which
infection was listed as an indicator for revision. The results remained unchanged.
We repeated the multivariate modeling on all 836 case-control pairs after multiple
imputation of missing values for variables with incomplete data (living status (1% missing),
fixation of femoral component (3% missing), weight (7% missing), height (11% missing),
and BMI (11% missing)). The set of pooled estimates based on these models was
qualitatively the same as the results of the main analysis, with odds ratios for the predictor
variables differing between the models by no more than 7%.
The results in an unmatched multivariate analysis were nearly identical to the results of the
primary matched analysis, with odds ratios for the predictor variables differing between the
two analyses by no more than 5%. In a secondary unmatched analysis, a variable
representing combinations of cemented and uncemented femoral and acetabular components
was substituted for the cemented femoral component variable. The category for uncemented
femoral and cemented acetabular components was excluded since only eight patients
received this type of prosthesis. In the analysis, those with cemented femoral and acetabular
components had greater risk for revision than subjects with uncemented femoral and
acetabular components (OR 1.5, 95% CI 1.0, 2.4) and those with cemented femoral and
uncemented acetabular components also had greater risk for revision than those with
uncemented femoral and acetabular components (OR 1.5, 95% CI 1.1, 1.9). Finally, we
found no evidence of an interaction between age at the time of surgery and cementing of the
femoral component on the risk of revision.
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We used a nested case-control study to examine predictors of revision risk in a cohort of
Medicare patients who received primary THR surgery between 7/1/1995 and 6/30/1996. We
followed the patients in Medicare files through 12/31/2008 and collected data on potential
predictors through medical record review. We found the following risk factors for failure
leading to revision THR surgery: younger age (65–75 years old versus > 75), greater height,
greater weight, a cemented femoral component, prior contralateral primary THR surgery,
other orthopedic surgery, and living with others (as opposed to living alone) at the time of
the primary THR. We also found that greater BMI was predictive of revision with similar
tertile odds ratios to those of weight. Reasons for revision surgery in our case sample were
similar to those reported previously in the literature.19
In contrast to earlier studies of long-term outcomes of total hip replacement utilizing
Medicare data, the cases in our study were verified to be revisions of the index primary THR
by subsequent medical chart review. This insures a more accurate case determination and
eliminates the substantial error inherent in Medicare data, which lacks information on
laterality.20
Similar to earlier studies, we found that younger age, in our case 65–75 years old compared
to >75, is associated with higher revision risk.4–7 We also found that a prior contralateral
primary THR surgery21 or other musculoskeletal surgery is associated with elevated risk of
revision. These factors may be surrogates for accessibility to health care, greater willingness
to undergo surgery, more favorable expectations of THR surgery, or may reflect orthopedic
comorbidity. Similarly, the suggestion in our data that living with others leads to higher risk
of revision surgery may be due to the fact that a social support network facilitates
transportation and rehabilitation post surgery.
The literature regarding the revision risk of cemented and uncemented prostheses is
discordant. Since 92% of both patients and controls in our study had uncemented acetabular
components, we were unable to study the effect of acetabular fixation. However, we found
that use of cemented femoral components was associated with increased revision risk. In an
unmatched sensitivity analysis, we found no evidence of an interaction between age at the
time of surgery and cementing of the femoral component on the risk of revision.
Furthermore, the same increased risk for cemented femoral components was found whether
the acetabular component was cemented or not. In contrast, an analysis of revision following
cemented and uncemented primary THR in New Zealand for cases from 1999–2006 found
similar rates of revision for cemented and uncemented femoral components, except in
patients over 75 years of age where revision rates for those with cemented components were
significantly lower.22 Also, in a meta-analysis of studies from 1991 to 2004, Morshed et
al.23 found that cemented THR had longer implant survival than uncemented in large subsets
of study populations, but they indicate that a more recent year of study publication was
associated with lower revision risk for uncemented fixation relative to cemented fixation.
The relative utilization of cemented and uncemented fixation for THR varies widely
throughout the world. For example, the rate of fully cemented THR in Canada in 2006–2007
was only 3% 24, whereas the Swedish rate in 2009 for cemented THR was about 70% and
cemented prostheses were the preferred choice for older patients (above mean age 70).25
Geographic differences in fixation preferences and patient populations, combined with the
ongoing development of new techniques and materials make this issue difficult to evaluate.
We found a strong association between risk of THR revision surgery and height, weight and
BMI. These findings contrast with recent studies reporting no significant association
between revision risk and BMI26–29 or body weight.26 Lubbeke et al. reported an increased
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risk of revision for obese patients compared to non-obese, although the risk was not
statistically significant: HR 2.2 (95% CI 0.9–5.3).28 Two studies did report lower post-
operative functional outcomes for obese patients, but did not find an elevated risk of
revision.27, 29 One possible explanation is that obesity may affect revision risk differently in
younger and older age groups. Our study was limited to patients at least 65 years old at the
time of the primary THR. It may be that in younger patients, obesity both loads the joint
(increasing risk of revision) and also reduces physical activity level (reducing risk), while in
older patients, such as those we studied, physical activity may be low irrespective of weight.
The lower percentages of obesity observed in European studies, such as those of Lubbeke et
al. (24%)28 and Haverkamp et al. (9%),26 as contrasted with our cohort (31% obese and
12% morbidly obese (BMI≥40)), suggest that some earlier studies may have lacked
sufficient power to show revision risk from BMI or body weight. We note that height had an
effect on revision that was independent of weight or BMI. This suggests that beyond mass or
obesity, the size of the individual’s frame affects revision risk. This effect could be due to
increased loads and moment arms associated with larger-framed persons.
We note that revision is not a perfect proxy for failure of primary THR. Patients with
symptomatic THR failure may not seek care, may seek care but not be offered revision
surgery, or may be offered the option and decline. These outcomes could arise from patient
comorbidities that make surgery less advisable or from patient preferences for undertaking
the procedure upon consideration of its potential risks and benefits. For example, older
patients may experience lower rates of prosthesis failure due to lower activity levels, but
they may also be less likely to undergo revision for prosthesis failure than younger patients
due to concerns about the safety of another major surgery. Similarly, the associations of
prior contralateral primary THR, other musculoskeletal surgery, and living alone, as noted
above, may relate more to the decision of whether to have revision for a failed THR than to
the risk of failure per se. We note as well that other musculoskeletal surgery may be a
marker for other orthopedic comorbidity, which in turn may be associated with revision risk.
The results of our study should be viewed in light of several limitations. Since our study
focused on persons at least 65 years old at the time of index THR in 1995–1996, we are
unable to make any conclusions about revision risk in patients younger than 65, who
comprise the fastest-growing group of THR recipients in the U.S.1, 30 Death is an important
competing risk in an elderly cohort. Indeed, 50% of our cohort had died by the end of the
twelve-year follow-up period. However, since each control had to be alive at the time of the
case’s revision, death did not arise as a competing risk in our analysis. Our ability to
investigate clinical factors relating to failure leading to revision was limited by the amount
of detail and lack of uniformity present in the medical charts collected from many different
hospitals, as well as by the unavailability of x-ray analysis. Because we asked hospitals for
medical records up to fifteen years old, some hospitals were unable to meet our requests due
to factors such as hospital closings or mergers and destruction or loss of records. While our
cases were similar to patients whose charts were unavailable in most respects, cases were
much more likely to have had their primary and revision surgeries in the same hospital than
patients whose charts were unavailable. This reflects the higher likelihood of obtaining both
the case primary and case revision records when both surgeries occurred in the same
hospital. This could imply a selection of a less mobile population, or of those more satisfied
with their primary THR surgery. In addition, the potential for bias due to unmeasured factors
and missing data remains an unavoidable limitation of this study. Finally, the advantage of
long-term follow-up data such as ours must be weighed against the fact that trends in clinical
practice and patient demographics are always changing.
This study of a Medicare population emphasizes that age between 65 and 75 years and
greater height and weight at the time of THR are potent risks for failure of THR leading to
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revision surgery. Since both height and weight are independent risk factors in multivariate
models, the risk factor for revision may not be obesity per se, but body size, potentially a
surrogate for the biomechanical load borne by the implant. This study also identifies prior
THR and other orthopedic surgeries as risk factors, possibly highlighting a connection of
access to health care or favorable expectations of surgery as motivators for revision surgery.
More detailed prospective studies would facilitate interpretation of these findings. We
conclude that the effects of age and larger body size on revision risk should be included in
discussions between surgeons and patients about the potential risk of failure of primary
THR.
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▪ Over 280,000 primary and 50,000 revision total hip replacements are
performed annually in the US.
▪ This is the first US population-based study of demographic, clinical and
operative risk factors for revision of primary THR.
▪ In this nested case-control study with twelve years of follow-up younger age
and greater body size (both weight and height) were associated with revision
risk, as was use of a cemented femoral component.
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Selection of eligible cases and potential controls.
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Random selection of one matched control per case.
Wright et al. Page 12





























































































































































































































































   



























   




























   



























   

































































































































































































































































































































Arthritis Care Res (Hoboken). Author manuscript; available in PMC 2013 December 01.
